| Year |
Citation |
Score |
| 2009 |
Lavie MC, Feydy A, Gossec L, Lavie F, Guerini H, Ayral X, Briot K, Kolta S, Dougados M, Drapé JL. Valeur diagnostique de l’IRM et de l’echographie-doppler puissance des talons au cours de la spondylarthropathie Journal De Radiologie. 90: 1325. DOI: 10.1016/S0221-0363(09)75270-9 |
0.355 |
|
| 2008 |
Sellam J, Miceli-Richard C, Gottenberg JE, Proust A, Ittah M, Lavie F, Loiseau P, Mariette X. Is Inhibitor of differentiation 3 involved in human primary Sjögren's syndrome? Rheumatology (Oxford, England). 47: 437-41. PMID 18296721 DOI: 10.1093/Rheumatology/Ken013 |
0.761 |
|
| 2008 |
Lavie F, Miceli-Richard C, Ittah M, Sellam J, Gottenberg JE, Mariette X. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome. Scandinavian Journal of Immunology. 67: 185-92. PMID 18201372 DOI: 10.1111/J.1365-3083.2007.02049.X |
0.78 |
|
| 2007 |
Pavy S, Dernis E, Lavie F, Maillefert JF, Mariette X, Schaeverbeke T, Cantagrel A, Claudepierre P, Flipo RM, Goupille P, Le Loet X, Saraux A, Tebib J, Wendling D, Combe B. Imaging for the diagnosis and follow-up of ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 338-45. PMID 17591453 DOI: 10.1016/J.Jbspin.2007.04.001 |
0.387 |
|
| 2007 |
Lavie F, Pavy S, Dernis E, Goupille P, Cantagrel A, Tebib J, Claudepierre P, Flipo RM, Le Loët X, Maillefert JF, Mariette X, Saraux A, Schaeverbeke T, Wendling D, Combe B. Pharmacotherapy (excluding biotherapies) for ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 346-52. PMID 17590370 DOI: 10.1016/J.Jbspin.2007.04.003 |
0.386 |
|
| 2007 |
Dernis E, Lavie F, Pavy S, Wendling D, Flipo RM, Saraux A, Cantagrel A, Claudepierrre P, Goupille P, Le Loët X, Maillefert JF, Mariette X, Schaeverbeke T, Tebib J, Combe B. Clinical and laboratory follow-up for treating and monitoring patients with ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 330-7. PMID 17590366 DOI: 10.1016/J.Jbspin.2007.04.002 |
0.397 |
|
| 2007 |
Terrier B, Ittah M, Tourneur L, Louache F, Soumelis V, Lavie F, Casadevall N, Candon S, Hummel A, Mariette X, Buzyn A. Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery. Haematologica. 92: e20-3. PMID 17405749 DOI: 10.3324/Haematol.11031 |
0.754 |
|
| 2007 |
Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus. Annals of the Rheumatic Diseases. 66: 790-7. PMID 17185325 DOI: 10.1136/Ard.2006.065656 |
0.746 |
|
| 2007 |
Lavie F, Miceli-Richard C, Ittah M, Sellam J, Gottenberg JE, Mariette X. Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production. Annals of the Rheumatic Diseases. 66: 700-3. PMID 17040963 DOI: 10.1136/Ard.2006.060772 |
0.773 |
|
| 2007 |
Dernis E, Lavie F, Salliot C, Flipo R, Saraux A, Maillefert J, Paul C, Goupille P, Cantagrel A, Claudepierre P, Gaudin P, Tebib J, Wendling D, Schaeverbeke T, Le Loët X, et al. Les traitements médicamenteux (hors biothérapie) dans la prise en charge de patients atteints de rhumatisme psoriasique périphérique : élaboration de recommandations pour la pratique clinique, à partir d’une analyse systématique de la littérature et de l’opinion d’experts Revue Du Rhumatisme. 74: 31-38. DOI: 10.1016/S1169-8330(07)78645-3 |
0.376 |
|
| 2007 |
Lavie F, Salliot C, Dernis E, Claudepierre P, Schaeverbeke T, Tebib J, Goupille P, Cantagrel A, Flipo RM, Gaudin P, Loët XL, Maillefert J, Paul C, Saraux A, Wendling D, et al. Pronostic et suivi du rhumatisme psoriasique de forme périphérique : élaboration de recommandations pour la pratique clinique, à partir d’une analyse systématique de la littérature et de l’opinion d’experts: Prognosis and follow-up of psoriatic arthritis with peripheral joint involvement: development of recommendations for clinical practice based on published evidence and expert opinion Revue Du Rhumatisme. 74: 23-30. DOI: 10.1016/S1169-8330(07)78644-1 |
0.375 |
|
| 2007 |
Salliot C, Dernis E, Lavie F, Cantagrel A, Gaudin P, Wendling D, Claudepierre P, Flipo R, Goupille P, Loët XL, Maillefert J, Paul C, Saraux A, Schaeverbeke T, Tebib J, et al. Pronostic et suivi du rhumatisme psoriasique de forme périphérique : élaboration de recommandations pour la pratique clinique, à partir d'une analyse systématique de la littérature et de l'opinion d'experts Revue Du Rhumatisme. 74: 15-22. DOI: 10.1016/S1169-8330(07)78643-X |
0.364 |
|
| 2007 |
Dernis E, Lavie F, Salliot C, Flipo R, Saraux A, Maillefert J, Paul C, Goupille P, Cantagrel A, Claudepierre P, Gaudin P, Tebib J, Wendling D, Schaeverbeke T, Le Loet X, et al. Les traitements médicamenteux (hors biothérapie) dans la prise en charge de patients atteints de rhumatisme psoriasique de forme périphérique: élaboration de recommandations pour la pratique clinique, à partir d'une analyse systématique de la littérature et de l'opinion d'experts Revue Du Rhumatisme. 74: 1030. DOI: 10.1016/J.Rhum.2007.10.579 |
0.374 |
|
| 2007 |
Sellam J, Miceli Richard C, Proust A, Ittah M, Lavie F, Gottenberg J, Loiseau P, Mariette X. Le gène Id3 est-il impliqué dans le syndrome de Sjögren? Revue Du Rhumatisme. 74: 1019-1020. DOI: 10.1016/J.Rhum.2007.10.553 |
0.759 |
|
| 2006 |
Gottenberg JE, Pallier C, Ittah M, Lavie F, Miceli-Richard C, Sellam J, Nordmann P, Cagnard N, Sibilia J, Mariette X. Failure to confirm coxsackievirus infection in primary Sjögren's syndrome. Arthritis and Rheumatism. 54: 2026-8. PMID 16732567 DOI: 10.1002/Art.21906 |
0.74 |
|
| 2006 |
Ittah M, Miceli-Richard C, Eric Gottenberg J, Lavie F, Lazure T, Ba N, Sellam J, Lepajolec C, Mariette X. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome. Arthritis Research & Therapy. 8: R51. PMID 16507175 DOI: 10.1186/Ar1912 |
0.763 |
|
| 2006 |
Gottenberg JE, Sellam J, Ittah M, Lavie F, Proust A, Zouali H, Sordet C, Sibilia J, Kimberly RP, Mariette X, Miceli-Richard C. No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome. Arthritis Research & Therapy. 8: R30. PMID 16507129 DOI: 10.1186/Ar1884 |
0.761 |
|
| 2006 |
Lavie F, Ittah M, Miceli-Richard C, Gottenberg J, Sellam J, Mariette X. Expression anormale de BAFF au sein des monocytes et lymphocytes T circulants de patients ayant un syndrome de Sjögren primitif Revue Du Rhumatisme. 73: 1227. DOI: 10.1016/J.Rhum.2006.10.564 |
0.781 |
|
| 2006 |
Ittah M, Miceli-Richard C, Gottenberg J, Lavie F, Sellam J, Mariette X. Induction de la cytokine BAFF (B Cell-Activating Factor of the TNF family) par les cellules épithéliales de glandes salivaires après infection virale Revue Du Rhumatisme. 73: 1201-1202. DOI: 10.1016/J.Rhum.2006.10.487 |
0.789 |
|
| 2006 |
Gottenberg J, Jacques S, Ittah M, Miceli-Richard C, Lavie F, Sellam J, Mariette X. Un nouveau rôle pathogène des interférons au cours des maladies auto-immunes: l'augmentation du rapport BAFF/delta-BAFF dans les cellules cibles de l'auto-immunité Revue Du Rhumatisme. 73: 1201. DOI: 10.1016/J.Rhum.2006.10.485 |
0.743 |
|
| 2006 |
Sellam J, Miceli-Richard C, Gottenberg J, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X. Expression du récepteur de BAFF (B cell Activator Factor of TNF Family), BAFF-R, au cours du syndrome de Sjögren primitif et du lupus systémique Revue Du Rhumatisme. 73: 1200. DOI: 10.1016/J.Rhum.2006.10.483 |
0.754 |
|
| 2006 |
Lavie F, Miceli-Richard C, Ittah M, Gottenberg J, Sellam J, Mariette X. Augmentation paradoxale de BAFF après déplétion lymphocytaire B induite par le rituximab dans les maladies auto-immunes systémiques Revue Du Rhumatisme. 73: 1092. DOI: 10.1016/J.Rhum.2006.10.171 |
0.769 |
|
| 2006 |
Dernis E, Lavie F, Pavy S, Wendling D, Flipo R-, Saraux A, Claudepierre P, Combe B. L'évaluation clinique et biologique dans la prise en charge et le suivi des personnes atteintes de spondylarthrite ankylosante : Etablissement de recommandations pour la pratique clinique Revue Du Rhumatisme. 73: 1070. DOI: 10.1016/J.Rhum.2006.10.114 |
0.353 |
|
| 2005 |
Terrier B, Lavie F, Miceli-Richard C, Azria A, Mariette X. Focal myositis with fasciitis and vasculitis revealing chronic lymphocytic leukaemia. Rheumatology (Oxford, England). 44: 1324-6. PMID 15941726 DOI: 10.1093/Rheumatology/Keh706 |
0.387 |
|
| 2005 |
Gottenberg JE, Lavie F, Abbed K, Gasnault J, Le Nevot E, Delfraissy JF, Taoufik Y, Mariette X. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome. Journal of Autoimmunity. 24: 235-42. PMID 15848046 DOI: 10.1016/J.Jaut.2005.01.015 |
0.37 |
|
| 2005 |
Gottenberg JE, Busson M, Cohen-Solal J, Lavie F, Abbed K, Kimberly RP, Sibilia J, Mariette X. Correlation of serum B lymphocyte stimulator and β2 microglobulin with autoantibody secretion and systemic involvement in primary Sjögren's syndrome Annals of the Rheumatic Diseases. 64: 1050-1055. PMID 15640273 DOI: 10.1136/Ard.2004.030643 |
0.478 |
|
| 2004 |
Lavie F, Miceli-Richard C, Quillard J, Roux S, Leclerc P, Mariette X. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome. The Journal of Pathology. 202: 496-502. PMID 15095277 DOI: 10.1002/Path.1533 |
0.527 |
|
| 2003 |
Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T, Kimberly R. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome. Annals of the Rheumatic Diseases. 62: 168-71. PMID 12525388 DOI: 10.1136/Ard.62.2.168 |
0.522 |
|
| Show low-probability matches. |